September 03, 2025 CDC Leadership Changes May Impact Vaccine Guidance Leadership changes at the CDC could affect vaccine guidance and public health policy, with potential implications for physicians and patient care. KFF Health News
September 03, 2025 Policy Shift Adjusts NIH Peer Review Role New NIH funding rules shift decision-making power from peer review panels to political appointees in determining future scientific grants. KFF Health News
August 27, 2025 FDA Approves LP.8.1 COVID-19 Vaccines LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration. Conexiant
August 25, 2025 What Does Xlear’s Lawsuit Mean for Physicians? Xlear's xylitol maker sues the FTC to loosen evidence rules on health claims, signaling a deregulatory push that could reshape supplement marketing. KFF Health News
August 18, 2025 US Vaccine Panels: Conflict and Recusal Trends Reported conflicts of interest in US vaccine advisory panels have dropped to historically low levels. Conexiant
August 14, 2025 Who Benefits From Vaccine Misinformation? US vaccination rates have declined in recent years, coinciding with increased public debate over vaccine safety and policy. KFF Health News
August 12, 2025 FDA Approves First Therapy for Non-cystic Fibrosis Bronchiectasis Brensocatib (Brinsupri) will offer a new treatment option for patients 12 years and older. Conexiant
August 11, 2025 FDA Grants Priority Review to Gepotidacin for Gonorrhea First potential oral treatment for gonorrhea supported by positive phase 3 trial results. Conexiant
August 11, 2025 FDA OKs Bioequivalent Iron Sucrose for CKD Anemia The FDA has approved a bioequivalent iron sucrose injection for treating iron deficiency anemia in patients with chronic kidney disease. Conexiant